Cargando…

Polymer Coated Oncolytic Adenovirus to Selectively Target Hepatocellular Carcinoma Cells

Despite significant advances in chemotherapy, the overall prognosis of hepatocellular carcinoma (HCC) remains extremely poor. HCC targeting strategies were combined with the tumor cell cytotoxicity of oncolytic viruses (OVs) to develop a more efficient and selective therapeutic system. OVs were coat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garofalo, Mariangela, Bellato, Federica, Magliocca, Salvatore, Malfanti, Alessio, Kuryk, Lukasz, Rinner, Beate, Negro, Samuele, Salmaso, Stefano, Caliceti, Paolo, Mastrotto, Francesca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309094/ https://www.ncbi.nlm.nih.gov/pubmed/34202714 http://dx.doi.org/10.3390/pharmaceutics13070949

Ejemplares similares

Dexamethasone Loaded Liposomes by Thin-Film Hydration and Microfluidic Procedures: Formulation Challenges
por: Al-Amin, MD, et al.
Publicado: (2020)

Combination Therapy of Novel Oncolytic Adenovirus with Anti-PD1 Resulted in Enhanced Anti-Cancer Effect in Syngeneic Immunocompetent Melanoma Mouse Model
por: Garofalo, Mariangela, et al.
Publicado: (2021)

Prospects of Replication-Deficient Adenovirus Based Vaccine Development against SARS-CoV-2
por: Garofalo, Mariangela, et al.
Publicado: (2020)

Novel combinatorial therapy of oncolytic adenovirus AdV5/3-D24-ICOSL-CD40L with anti PD-1 exhibits enhanced anti-cancer efficacy through promotion of intratumoral T-cell infiltration and modulation of tumour microenvironment in mesothelioma mouse model
por: Garofalo, Mariangela, et al.
Publicado: (2023)

Oncolytic adenoviruses coated with MHC-I tumor epitopes for a new oncolytic vaccine platform
por: Capasso, Cristian, et al.
Publicado: (2015)

Systemic Administration and Targeted Delivery of Immunogenic Oncolytic Adenovirus Encapsulated in Extracellular Vesicles for Cancer Therapies
por: Garofalo, Mariangela, et al.
Publicado: (2018)

Optimization of Early Steps in Oncolytic Adenovirus ONCOS-401 Production in T-175 and HYPERFlasks
por: Kuryk, Lukasz, et al.
Publicado: (2019)

Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma
por: Capasso, Cristian, et al.
Publicado: (2015)

From Immunosuppression to Immunomodulation - Turning Cold Tumours into Hot
por: Garofalo, Mariangela, et al.
Publicado: (2022)

From Conventional Therapies to Immunotherapy: Melanoma Treatment in Review
por: Kuryk, Lukasz, et al.
Publicado: (2020)

Novel Insights Into Mesothelioma Therapy: Emerging Avenues and Future Prospects
por: Kuryk, Lukasz, et al.
Publicado: (2022)

Oncolytic Adenoviruses Armed with Co-Stimulatory Molecules for Cancer Treatment
por: Gryciuk, Aleksander, et al.
Publicado: (2023)

Antitumor‐specific T‐cell responses induced by oncolytic adenovirus ONCOS‐102 (AdV5/3‐D24‐GM‐CSF) in peritoneal mesothelioma mouse model
por: Kuryk, Lukasz, et al.
Publicado: (2018)

Influence of Folate-Targeted Gold Nanoparticles on Subcellular Localization and Distribution into Lysosomes
por: Daniele, Raffaella, et al.
Publicado: (2023)

Mannosylated Polycations Target CD206(+) Antigen-Presenting Cells and Mediate T-Cell-Specific Activation in Cancer Vaccination
por: Bellato, Federica, et al.
Publicado: (2022)

Abscopal effect when combining oncolytic adenovirus and checkpoint inhibitor in a humanized NOG mouse model of melanoma
por: Kuryk, Lukasz, et al.
Publicado: (2019)

Pullulan Based Bioconjugates for Ocular Dexamethasone Delivery
por: Kicková, Eva, et al.
Publicado: (2021)

Combination of immunogenic oncolytic adenovirus ONCOS-102 with anti-PD-1 pembrolizumab exhibits synergistic antitumor effect in humanized A2058 melanoma huNOG mouse model
por: Kuryk, Lukasz, et al.
Publicado: (2018)

Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunity
por: Hirvinen, Mari, et al.
Publicado: (2016)

Safety Profiles and Antitumor Efficacy of Oncolytic Adenovirus Coated with Bioreducible Polymer in the Treatment of a CAR Negative Tumor Model
por: Jung, Soo-Jung, et al.
Publicado: (2014)

Oncolytic Adenoviruses in Gastrointestinal Cancers
por: Yokoda, Raquel T., et al.
Publicado: (2018)

Oncolytic Adenoviruses in Cancer Treatment
por: Alemany, Ramon
Publicado: (2014)

Oncolytic Adenovirus in Cancer Immunotherapy
por: Peter, Malin, et al.
Publicado: (2020)

Oncolytic Adenoviruses for Cancer Therapy
por: Tripodi, Lorella, et al.
Publicado: (2021)

Concepts in Oncolytic Adenovirus Therapy
por: Mantwill, Klaus, et al.
Publicado: (2021)

A Renaissance for Oncolytic Adenoviruses?
por: Blanchette, Paola, et al.
Publicado: (2023)

Toxicological and bio-distribution profile of a GM-CSF-expressing, double-targeted, chimeric oncolytic adenovirus ONCOS-102 – Support for clinical studies on advanced cancer treatment
por: Kuryk, Lukasz, et al.
Publicado: (2017)

Increasing the Efficacy of Oncolytic Adenovirus Vectors
por: Toth, Karoly, et al.
Publicado: (2010)

Designer Oncolytic Adenovirus: Coming of Age
por: Baker, Alexander T., et al.
Publicado: (2018)

Oncolytic Adenovirus: Prospects for Cancer Immunotherapy
por: Zhao, Yaqi, et al.
Publicado: (2021)

Oncolytic adenovirus for treatment of malignant ascites
por: Hemminki, Akseli, et al.
Publicado: (2022)

Adenovirus as a Vector and Oncolytic Virus
por: Matsunaga, Wataru, et al.
Publicado: (2023)

Chimeric oncolytic Ad5/3 virus replicates and lyses ovarian cancer cells through desmoglein‐2 cell entry receptor
por: Kuryk, Lukasz, et al.
Publicado: (2020)

Oncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic Applications
por: Uusi-Kerttula, Hanni, et al.
Publicado: (2015)

Enhancing the antitumor activity of an engineered TRAIL-coated oncolytic adenovirus for treating acute myeloid leukemia
por: Wang, Zixuan, et al.
Publicado: (2020)

Next generation oncolytic viruses expressing PADI1 and TIMP2 exhibit anti-tumor activity against melanoma in nude and humanized mouse models
por: Kuryk, Lukasz, et al.
Publicado: (2023)

A novel oncolytic adenovirus based on simian adenovirus serotype 24
por: Cheng, Tao, et al.
Publicado: (2017)

Challenges and progress toward tumor-targeted therapy by systemic delivery of polymer-complexed oncolytic adenoviruses
por: Thambi, Thavasyappan, et al.
Publicado: (2022)

Oncolytic Adenovirus—A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC
por: Abudoureyimu, Mubalake, et al.
Publicado: (2019)

Oncolytic adenovirus-mediated therapy for prostate cancer
por: Sweeney, Katrina, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bgrvstpev4kn5hb8lts9kbo6bh